Injecting DNA into injured horse tendons and ligaments can cure lameness, new research involving scientists at Kazan Federal University, Moscow State Academy and The University of Nottingham has found.
The gene therapy technology was used in horses that had gone lame due to injury and within two to three weeks the horses were able to walk and trot. Within just two months they were back to full health, galloping and competing.
The study has big implications not just for the veterinary world but the future of human medicine – injuries like these are common in people as well as animals, not just in lameness but in other illnesses and diseases from the legs and arms through to the back and hips.
The new findings are the result of a partnership between the Kazan Federal University and Moscow State Academy of Veterinary Medicine and Biotechnology and Nottingham’s School of Veterinary Medicine and Science.
Dr Catrin Rutland, Assistant Professor of Anatomy and Developmental Genetics, led the work at Nottingham.
She said: “This pioneering study advances not only equine medicine but has real implications for how other species and humans are treated for lameness and other disorders in the future. The horses returned to full health after their injuries and did not have any adverse side effects. This is a very exciting medical innovation.”
The ground-breaking, international study, published in the academic journal Frontiers in Veterinary Science, demonstrated gene therapy using a combination of the Vascular Endothelial Growth Factor gene VEGF164, to enhance the growth of blood vessels and bone morphogenetic protein 2 (BMP2), which plays an important role in the development of bone and cartilage.
Both the genes were derived from horses, resulting in the biosynthesis of natural horse proteins in the treated animals. They were cloned into a single plasmid DNA, which is both biologically safe and unlikely to provoke an immune reaction from the body.
Current medical therapies have a relapse rate of 60 per cent and even the best regenerative medicine treatments have a 20 per cent relapse rate and take five to six months to work.
The new therapy is therefore very promising as it offers a much faster healing time and could significantly reduce relapse rates.
The results also showed that the tissue within the horses limbs has also fully recovered and 12 months after the revolutionary treatment the horses were completely fit, active and pain free.
Many medicines and treatments have adverse effects, but no side effects or bad reactions were seen in the horses treated.
Professor Albert Rizvanov, who led the study and is based at Kazan Federal University, said: “Advancing medicine, relieving pain and restoring function were the main aims of this study. We have shown that these are possible and within a much shorter time span than treatments available at the moment. In addition, we could use this type of therapy in other injuries and in many other situations ranging from fertility problems through to spinal cord injuries.
“Our next step is to secure more funding for an even larger trial to help more animals and improve and treat other disorders in the hope that one day we can routinely use this treatment around the world.”
The Latest on: Gene therapy
- Children's Hospital of Philadelphia opens $75 million gene-therapy research lab on November 11, 2018 at 7:52 pm
The Children’s Hospital of Philadelphia opened a new clinical manufacturing facility in its campus in University City. The $75 million underground lab will serve as a cell and gene-therapy testing and ... […]
- live Gene Therapy on November 11, 2018 at 9:46 am
The code has been copied to your clipboard. The URL has been copied to your clipboard High hopes of gene therapy come with fears about its cost. On the next edition of Press Conference USA, Janet Lamb... […]
- Gene Therapy Markets: Global and US Analysis (2018-2020) - Rising Focus to Accelerate Commercialization of Gene Therapy in Developed Nations on November 9, 2018 at 2:56 am
The "Global & US Gene Therapy Market Forecast to 2020" report has been added to ResearchAndMarkets.com's offering. Gene therapy is one of the most widely researched fields in the healthcare industry. […]
- Gene Therapy Market to Reach US$ 5164.03 Million by 2026, Says TMR on November 8, 2018 at 6:06 am
Albany, NY, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) has published a new report titled, “Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends ... […]
- The end of joint replacement surgery? Gene therapy developed for dogs could help people on November 7, 2018 at 6:28 pm
WESTMINSTER, CO (KCNC) -- Some dog owners say their dogs are getting a new lease on life thanks to a medical breakthrough -- a gene therapy that could Baer is a black lab. Each step he takes is brutal... […]
- Phoenix Nest Inc. Licenses a Sanfilippo Syndrome Gene Therapy From the University of Manchester and is Preparing for a Clinical Trial on November 7, 2018 at 10:15 am
NEW YORK, Nov. 7, 2018 /PRNewswire/ -- Phoenix Nest Inc. exclusively licensed a gene therapy for Sanfilippo syndrome (also known as Mucopolysaccharidosis IIIC, (MPSIIIC)) from The University of Manche... […]
- Rocket Pharmaceuticals Announces FDA Clearance of IND Application for RP-L102 Gene Therapy for Fanconi Anemia on November 7, 2018 at 5:10 am
- Patients to Be Treated with RP-L102 under “Process B” Incorporating Higher Cell Doses, Transduction Enhancers, and Commercial-grade Vector Manufacturing and Cell Processing – - U.S. Trial ... […]
- Gene therapy injection into spinal cord halts ALS in adult mice on November 6, 2018 at 6:36 am
A new delivery method could take us a step closer to a gene therapy for amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder in which nerve cells progressively stop working throughout the ... […]
- New gene therapy reprograms brain glial cells into neurons on November 5, 2018 at 9:18 am
A new gene therapy can turn certain brain glial cells into functioning neurons, which in turn could help repair the brain after a stroke or during neurological disorders like Alzheimer's or ... […]
- Realizing the potential of gene therapy for neurological disorders on November 4, 2018 at 12:04 pm
SAN DIEGO -- Promising findings from preclinical animal studies show the potential of gene therapy for treating incurable neurological disorders. In new research presented today, scientists successful... […]
via Google News and Bing News